A Chinese patent medicine's long-term efficacy on non-dialysis patients with CKD stages 3-5: a retrospective cohort study

• Main Authors: Hui-Fen Chen (Author), Yu-Jie Lin (Author), Yan Han (Author), Xian-Long Zhang (Author), Ruo-Bing Wang (Author), Jun-Hui Chen (Author), Ying Pi (Author), Li-Zhe Fu (Author), Fang Tang (Author), Xi-Na Jie (Author), Xiao-Na Tang (Author), Xu-Sheng Liu (Author), Yi-Fan Wu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

BackgroundChinese patent medicine is commonly used in China as an important treatment mechanism to thwart the progression of chronic kidney disease (CKD) stages 3-5, among which Niaoduqing granules are a representative Chinese patent medicine; however, its long-term efficacy on CKD prognosis remains...